Polyclonal spread of erythromycin-resistant Streptococcus agalactiae in Southern Taiwan

Microbial Drug Resistance

Volumn 10, Issue 4, 2004, Pages 306-312

  Ko, Wen Chien ^a,b   Yan, Jing Jou ^a,b   Lee, Nan Yao ^a   Wu, Hsiu Mei ^b   Wu, Jiunn Jong ^b,c  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; LINCOSAMIDE; MACROLIDE; STREPTOGRAMIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; ERMB GENE; ERMTR GENE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; STREPTOCOCCUS AGALACTIAE; TAIWAN;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS SP. 'GROUP B';

EID: 11844270479     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2004.10.306     Document Type: Article

References (30)

1. Betriu, C., E. Culebras, M. Gómez, I. Rodríguez-Avial, B.A. Sánchez, M.C. Ágreda, and J.J. Piczo. 2003. Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae. Antimicrob. Agents Chemother. 47:1112-1114.
2. Bozdogan, B., L. Berrezouga, M.S. Kuo, D.A. Yurek, K.A. Farley, B.J. Stockman, and R. Leclercq. 1999. A new resistance gene, linB, conferring resistance to lincosamides by nucleotidylation in Enterococcus faecium HM1025. Antimicrob Agents Chemother. 43:925-929.
3. Chang, S.C., Y.C. Chen, K.T. Luh, and W.C. Hsieh. 1995. Macrolides resistance of common bacteria isolated from Taiwan. Diagn. Microbiol. Infect. Dis. 23:147-154.
4. Chu, G., D. Vollrath, and R.W. Davis. 1986. Separation of large DNA molecules by contour-clamped homogeneous electric fields. Science 234:1582-1585.
5. de Azavedo, J.C., M. McGavin, C. Duncan, D.E. Low, and A. McGeer. 2001. Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. Antimicrob. Agents Chemother. 45:3504-3508.
6. Diekema, D.J., J.I. Andrews, H. Huynh, P.R. Rhomberg, S.R. Doktor, J. Beyer, V.D. Shortridge, R.K. Flamm, R.N. Jones, and M.A. Pfaller. 2003. Molecular epidemiology of macrolide resistance in neonatal bloodstream isolates of group B streptococci. J. Clin. Microbiol. 41:2659-2661.
7. Farley, M.M. 2001. Group B streptococcal disease in nonpregnant adults. Clin. Infect. Dis. 33:556-561.
8. Fitoussi, F., C. Loukil, I. Gros, O. Clermont, P. Mariani, S. Bonacorsi, I. Le Thomas, D. Deforche, and E. Bingen. 2001. Mechanisms of macrolide resistance in clinical group B streptococci isolates in France. Antimicrob. Agents Chemother. 45:1889-1891.
9. Hsueh, P.R., L.J. Teng, L.N. Lee, S.W. Ho, P.C. Yang, and K.T. Luh. 2001. High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan. Antimicrob. Agents Chemother. 45:3205-3208.
10. Hsueh, P.R., C.Y. Liu, and K.T. Luh. 2002. Current status of antimicrobial resistance in Taiwan. Emerg. Infect. Dis. 8:132-137.
11. Hsueh, P.R., and K.T. Luh. 2002. Antimicrobial resistance in Streptococcus pneumoniae, Taiwan. Emerg. Infect. Dis. 8:1487-1491.
12. Hsueh, P.R., L.J. Teng, L.N. Lee, P.C. Yang, S.W. Ho, H.C. Lue, and K.T. Luh. 2002. Increased prevalence of erythromycin resistance in streptococci: substantial upsurge in erythromycin-resistant M phenotype in Streptococcus pyogenes (1979-1998) but not in Streptococcus pneumoniae (1985-1999) in Taiwan. Microb. Drug Resist. 8:27-33.
13. Ko, W.C., H.C. Lee, L.R. Wang, C.T. Lee, A.J. Liu, and J.J. Wu. 2001. Serotyping and antimicrobial susceptibility of group B streptococcus over an eight-year period in southern Taiwan. Eur. J. Clin. Microbiol. Infect. Dis. 20:334-339.
14. Le Thomas-Bories, I., F. Fitoussi, P. Mariani-Kurkdjian, J. Raymond, N. Brahimi, P. Bidet, V. Lefranc, and E. Bingen. 2001. Clonal relationship between U.S. and French serotype V group B streptococcus isolates. J. Clin. Microbiol. 39:4526-4528.
15. Liu, J.W., J.J. Wu, W.C. Ko, and Y.C. Chuang. 1997. Clinical characteristics and antimicrobial susceptibility of invasive group B streptococcal infections in nonpregnant adults in Taiwan. J. Formos. Med. Assoc. 96:628-633.
16. Matsubara, K., Y. Nishiyama, K. Katayama, G. Yamamoto, M. Sugiyama, T. Murai, and K. Baba. 2001. Change of antimicrobial susceptibility of group B streptococci over 15 years in Japan. J. Antimicorb. Chemother. 48:579-582.
17. Muñoz, P., A. Llancaqueo, M. Rodríguez-Créxems, T. Peláez, L. Martin, and E. Bouza. 1997. Group B streptococcus bacteremia in nonpregnant adults. Arch. Intern. Med. 157:213-216.
18. National Committee for Clinical Laboratory Standards. 2002. Performance standards for antimicrobial susceptibility testing. Twelfth information supplement, M100-S2. National Committee for Clinical Laboratory Standards, Wayne, PA.
19. Piggot, P.J., M. Amjad, J.J. Wu, H. Sandoval, and J. Castro. 1990. Genetic and physical maps of Bacillus subtilis, In C.R. Harwood and S.M. Cutting (eds.), Molecular biology methods for Bacillus. John Wiley & Sons Ltd., West Sussex, England, pp. 493-543.
20. Ruess, M., U. Muller, A. Sander, and R. Berner. 2000. Antimicrobial susceptibility patterns of Streptococcus agalactiae in a German university hospital. Scand. J. Infect. Dis. 32:623-626.
21. Schuchat, A. 1998. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin. Microbiol. Rev. 11:497-513.
22. Stylianopoulos, A., N. Kelly, and S. Garland. 2002. Is penicillin and/or erythromycin resistance present in clinical isolates of group B streptococcus in our community? Aust. N.Z. J. Obstet. Gynaecol. 42:543-544.
23. Teng, L.J., P.R. Hsueh, Y.C. Chen, S.W. Bo, and K.T. Luh. 1998. Antimicrobial susceptibility of viridans group streptococci in Taiwan with an emphasis on the high rates of resistance to penicillin and macrolides in Streptococcus oralis. J. Antimicrob. Chemother. 41:621-627.
24. Teng, L.J., P.R. Hseuh, S.W. Ho, and K.T. Luh. 2001. High prevalence of inducible erythromycin resistance among Streptococcus bovis isolates in Taiwan. Antimicrob. Agents Chemother. 45:3362-3365.
25. Tyrrell, G.J., L.D. Senzilet, J.S. Spika, D.A. Kertesz, M. Alagaratnam, M. Lovgren, and J.A. Talbot. 2000. Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population-based, active laboratory surveillance study-1996. J. Infect. Dis. 182:168-173.
26. Uh, Y., I.H. Jang, G.Y. Hwang, K.J. Yoon, and Y.W. Song. 2001. Emerging erythromycin resistance among group B streptococci in Korea. Eur. J. Clin. Microbiol. Infect. Dis. 20:52-55.
27. Von Both, U., M. Ruess, U. Mueller, K. Fluegge, A. Sander, and R. Berner. 2003. A serotype V clone is predominant among erythromycin-resistant Streptococcus agalactiae isolates in a southwestern region of Germany. J. Clin. Microbiol. 41:2166-2169.
28. Yan, J.J., H.M. Wu, A.H. Huang, H.M. Fu, C.T. Lee, and J.J. Wu. 2000. Prevalence of polyclonal mefA-containing isolates among erythromycin-resistant group A streptococci in southern Taiwan. J. Clin. Microbiol. 38:2475-2479.
29. Wilder-Smith, E., K.M. Chow, R. Kay, M. Ip, and N. Tee. 2000. Group B streptococcal meningitis in adults: recent increase in southeast Asia. Aust. N. Z. J. Med. 30:462-465.
30. Wu, J.J., K.Y. Lin, P.R. Hseuh, J.W. Liu, H.I. Pan, and S.M. Sheu. 1997. High incidence of erythromycin-resistant streptococci in Taiwan. Antimicrob. Agents Chemother. 41:844-846.